Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Solid Biosciences (SLDB) Non Operating Income (2017 - 2024)

Solid Biosciences' Non Operating Income history spans 8 years, with the latest figure at $199000.0 for Q4 2024.

  • For Q4 2024, Non Operating Income rose 105.93% year-over-year to $199000.0; the TTM value through Dec 2024 reached $2.9 million, up 164.66%, while the annual FY2024 figure was $652000.0, 40.46% down from the prior year.
  • Non Operating Income for Q4 2024 was $199000.0 at Solid Biosciences, down from $2.5 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $20.2 million in Q4 2022 and bottomed at -$3.4 million in Q4 2023.
  • The 5-year median for Non Operating Income is $1000.0 (2020), against an average of $1.3 million.
  • The largest annual shift saw Non Operating Income tumbled 1500.0% in 2021 before it surged 91936.36% in 2022.
  • A 5-year view of Non Operating Income shows it stood at -$20000.0 in 2020, then dropped by 10.0% to -$22000.0 in 2021, then soared by 91936.36% to $20.2 million in 2022, then plummeted by 116.62% to -$3.4 million in 2023, then skyrocketed by 105.93% to $199000.0 in 2024.
  • Per Business Quant, the three most recent readings for SLDB's Non Operating Income are $199000.0 (Q4 2024), $2.5 million (Q3 2024), and -$2.3 million (Q2 2024).